Latest News AcuFocus Appoints Alan Waterhouse President and COO; William Link, PhD Becomes Chairman of the Board By Staff Friday, July 29, 2016 12:21 AM Alan Waterhouse, president and COO of AcuFocus. IRVINE, Calif.—AcuFocus, developer of the Kamra corneal inlay and IC-8 IOL, announced that Alan Waterhouse has been appointed president and chief operating officer (COO) and William Link, PhD, has joined the company as chairman of the board. Waterhouse will also take a seat on the board of directors. Waterhouse and Link will replace Jim Mazzo, current chairman and chief executive officer, who will join Carl Zeiss Meditec as global president of ophthalmology effective Aug. 1, 2016. (see related article above)Waterhouse brings to AcuFocus more than 21 years of health care experience, having joined the company as COO in 2015. In past roles, he has served as vice-president or president of Abbott Labs, Advanced Medical Optics, Cardinal Health (Pyxis Corp./PCI Services), and the Asteres Corp. He has participated in over a dozen M&A deals, raised significant venture capital, and been a part of management teams that have created over $4.5B in market value.Kamra corneal inlay beside a contact lens. Link is managing director and co-founder of Versant Ventures, a health care investment firm. He has more than two decades of operations experience in the healthcare industry and extensive knowledge of the ophthalmic market.The Kamra inlay helps presbyopic patients restore their near vision while maintaining their distance vision. It is commercially available in 50 countries, including the U.S.The IC-8 IOL provides a range of vision across various distances, from near to far, and is specifically designed for patients with cataracts. The IOL is CE marked and currently available in select markets. It is not yet approved by the FDA for use in the U.S.